Correction to: Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)?

The original version of this article unfortunately contained a mistake. There was a typo in the second sentence of the paragraph under the section Was the Dose of Drugs Fair?;"320 mg twice a day" should read"160mg twice a day". The corrected paragraph is shown below.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research